Protalix BioTherapeutics
PLX
#8663
Rank
C$0.18 B
Marketcap
$2.49
Share price
-0.57%
Change (1 day)
5.20%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of September 2024 : C$39.24 Million

According to Protalix BioTherapeutics 's latest financial reports the company has C$39.24 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$59.1 M96.37%
2022-12-31C$30.09 M-39.42%
2021-12-31C$49.68 M1.09%
2020-12-31C$49.14 M111.5%
2019-12-31C$23.23 M-54.88%
2018-12-31C$51.5 M-19.93%
2017-12-31C$64.32 M-24.36%
2016-12-31C$85.04 M-19.73%
2015-12-31C$0.10 B66.7%
2014-12-31C$63.55 M-30.9%
2013-12-31C$91.97 M77.74%
2012-12-31C$51.74 M88.4%
2011-12-31C$27.46 M-23.46%
2010-12-31C$35.88 M-58.03%
2009-12-31C$85.5 M65.1%
2008-12-31C$51.79 M-16.01%
2007-12-31C$61.66 M130.72%
2006-12-31C$26.72 M384.2%
2005-12-31C$5.51 M714.81%
2004-12-31C$0.67 M-28.64%
2003-12-31C$0.94 M-25.58%
2002-12-31C$1.27 M-12.55%
2001-12-31C$1.45 M-39.45%
2000-12-31C$2.4 M13.69%
1999-12-31C$2.11 M6.88%
1998-12-31C$1.98 M153.24%
1997-12-31C$0.78 M-25.18%
1996-12-31C$1.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.35 B 811.22%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.75 B 4,380.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.25 B 36,209.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.75 B 12,009.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel